GE HealthCare Technologies Inc.
GEHCV
NASDAQ Global Select56.00
USD
-2.38
- -
CIK
0001932393
Return %
Stock
S&P500
1Y
-6.67
26.53
3Y
-6.67
76.60
5Y
-6.67
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Peter J. Arduini
- Full Time Employees
- 51,000
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 500 W. Monroe Street Chicago IL United States of America 60661
- IPO Date
- Dec 15, 2022
- CIK
- 0001932393
- Website
- gehealthcare.com
- Similar Companies
- Business
- GE HealthCare Technologies Inc. (GEHC) develops, manufactures, and markets advanced medical products and digital solutions for diagnostic, therapeutic, and monitoring applications worldwide. The company offers a broad portfolio of imaging systems, including magnetic resonance (MR), computed tomography (CT), molecular imaging, X-ray, ultrasound, and women's health products; patient care solutions such as patient monitoring systems, anesthesia machines, and maternal-infant care equipment; pharmaceutical diagnostics, including contrast media and molecular imaging agents; and digital solutions encompassing enterprise data management software, advanced visualization tools, and AI-enabled platforms like Edison. GE HealthCare serves healthcare providers, pharmaceutical companies, and research institutions across more than 160 countries, with a focus on precision medicine, productivity enhancement, and patient outcomes in segments including medical imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics. Founded in 2023 as a spin-off from General Electric Company and headquartered in Chicago, Illinois, the company operates through subsidiaries and maintains global manufacturing and R&D facilities in the United States, Europe, Asia, and other regions. In recent developments, GE HealthCare expanded its AI capabilities with the launch of new deep learning image reconstruction applications for its CT scanners in 2025; formed strategic partnerships, including collaborations with NVIDIA for AI-driven drug discovery and with Caption Health for AI-powered cardiac ultrasound; and continued growth through acquisitions such as Prismatic Sensors AB in 2024 to bolster photon-counting CT technology, alongside investments in sustainable manufacturing and emerging markets expansion.
GE Healthcare stock to start trading as separation from GE is completed
GE HealthCare Completes Spin-Off and Begins Trading on Nasdaq
General Electric Healthcare Spinoff to Join S&P 500